78
16
Growth Score
-8 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
879351
CanniOasis is a personalized cannabinoid-based biopharma company.
- Kah Meng Lim: CSO
- Lisa Hii: Group Accountant
About the Company
CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitive advantage for the Company is its midbrain organoid model that
will substantially de-risk and shorten the drug development process for neurological disorders.
